Literature DB >> 11874475

Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors.

Metin Artuc1, U Muscha Steckelings, Beate M Henz.   

Abstract

As mast cells have been implicated in cutaneous repair processes, we have examined the ability of human mast cells to produce important epithelial and fibroblast growth factors or to stimulate the production of such factors in dermal fibroblasts. Isolated, highly purified human dermal mast cells and human leukemic mast cells were examined for mRNA and partly also for protein expression of these molecules as such or after preincubation with interleukin-4, stem cell factor, or with phorbol myristate acetate. In addition, mast cells were studied for their ability to induce fibroblast growth factor 2 and fibroblast growth factor 7 secretion from dermal fibroblasts. Both dermal and leukemic mast cells expressed fibroblast growth factor 2, fibroblast growth factor 7, and heparin-binding epidermal growth factor, but not hepatocyte growth factor at mRNA level, and dermal mast cells expressed fibroblast growth factor 10 in addition. At protein level, spontaneous fibroblast growth factor 2 secretion was noted that was markedly enhanced by phorbol myristate acetate, whereas no fibroblast growth factor 7 protein was detected under these conditions. Instead, human mast cell-1 supernatants induced enhanced fibroblast growth factor 7 secretion from dermal fibroblasts, with phorbol-myristate-acetate-stimulated supernatants being more effective. This effect could be reproduced with histamine and was H1-receptor mediated. Tryptase was ineffective but stimulated instead fibroblast growth factor 2 secretion from fibroblasts. These data demonstrate for the first time the ability of mast cells to express and/or secrete several growth factors of the fibroblast growth factor family as well as heparin-binding epidermal growth factor directly or indirectly via stimulation of fibroblasts, underlining the potentially pivotal role of these cells during human tissue repair and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874475     DOI: 10.1046/j.0022-202x.2001.01705.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  28 in total

1.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

2.  Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12.

Authors:  Fumiaki Nakayama; Takeshi Yasuda; Sachiko Umeda; Masahiro Asada; Toru Imamura; Viktor Meineke; Makoto Akashi
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 3.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

4.  Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.

Authors:  F H Hsieh; P Sharma; A Gibbons; T Goggans; S C Erzurum; S J Haque
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

6.  Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium.

Authors:  Olivia L Wei; Ashley Hilliard; Daniel Kalman; Melanie Sherman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

8.  Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.

Authors:  Maya Vladova Gulubova
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors.

Authors:  Maria Célia Jamur; Andréa N Moreno; Luciana Fc Mello; Devandir A Souza Júnior; Maria Rita C Campos; Maria Verônica D Pastor; Ana Cristina G Grodzki; Deise C Silva; Constance Oliver
Journal:  BMC Immunol       Date:  2010-06-24       Impact factor: 3.615

10.  Our perception of the mast cell from Paul Ehrlich to now.

Authors:  Michael A Beaven
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.